A detailed history of Tower House Partners LLP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Tower House Partners LLP holds 35,678 shares of CRL stock, worth $6.63 Million. This represents 46.23% of its overall portfolio holdings.

Number of Shares
35,678
Previous 34,459 3.54%
Holding current value
$6.63 Million
Previous $6.78 Million 14.64%
% of portfolio
46.23%
Previous 27.97%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$197.11 - $250.07 $240,277 - $304,835
1,219 Added 3.54%
35,678 $7.77 Million
Q3 2022

Nov 14, 2022

SELL
$182.44 - $250.54 $2.74 Million - $3.76 Million
-15,011 Reduced 30.34%
34,459 $6.78 Million
Q2 2022

Aug 15, 2022

SELL
$204.13 - $302.4 $1.13 Million - $1.67 Million
-5,530 Reduced 10.05%
49,470 $10.6 Million
Q1 2022

May 16, 2022

SELL
$255.51 - $362.11 $8.67 Million - $12.3 Million
-33,925 Reduced 38.15%
55,000 $15.6 Million
Q4 2021

Feb 14, 2022

BUY
$351.38 - $448.68 $241,046 - $307,794
686 Added 0.78%
88,925 $33.5 Million
Q3 2021

Nov 15, 2021

SELL
$372.64 - $458.3 $13 Million - $16 Million
-34,974 Reduced 28.38%
88,239 $36.4 Million
Q2 2021

Aug 17, 2021

SELL
$294.17 - $371.65 $10 Million - $12.6 Million
-34,028 Reduced 21.64%
123,213 $45.6 Million
Q1 2021

May 17, 2021

SELL
$249.67 - $299.48 $7.46 Million - $8.95 Million
-29,897 Reduced 15.98%
157,241 $45.6 Million
Q4 2020

Mar 05, 2021

SELL
$222.0 - $252.62 $5.08 Million - $5.78 Million
-22,862 Reduced 10.89%
187,138 $46.8 Million
Q3 2020

Nov 16, 2020

SELL
$175.56 - $226.45 $3.51 Million - $4.53 Million
-20,000 Reduced 8.7%
210,000 $47.6 Million
Q2 2020

Aug 10, 2020

BUY
$118.84 - $189.72 $27.3 Million - $43.6 Million
230,000 New
230,000 $40.1 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.45B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Tower House Partners LLP Portfolio

Follow Tower House Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower House Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Tower House Partners LLP with notifications on news.